FBXO36P1

Across TCGA pan-cancer cohorts, FBXO36P1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated FBXO36P1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher FBXO36P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated FBXO36P1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

LUAD, HNSC, and MESO are the cancer types where FBXO36P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Quartile	II,III,IV	0.713	0.441	<.001	76	view →
HNSC	DFS	Median	IV	0.648	0.461	<.001	60	view →
MESO	DFS	Tertile	III,IV	0.236	0.442	.002	53	view →
KICH	OS	Tertile	All	0.313	0.917	.001	33	view →
THCA	DFS	Tertile	IV	0.361	0.950	<.001	29	view →
LIHC	DFS	Quartile	II,III,IV	0.554	0.220	.002	21	view →
CESC	OS	Quartile	All	0.934	0.811	.007	16	view →
STAD	OS	Median	III,IV	0.482	0.204	.008	12	view →
READ	OS	Tertile	III,IV	0.720	0.409	.033	12	view →
LGG	DFS	Median	All	0.672	0.784	.002	10	view →
UVM	DFS	Tertile	III,IV	0.129	0.673	.017	9	view →
CHOL	DFS	Tertile	III,IV	0.255	0.791	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

FBXO36P1–LUAD (OS)

Open the LUAD breakdown →